These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23442081)

  • 1. Bioequivalence of inhaled drugs: fundamentals, challenges and perspectives.
    Apiou-Sbirlea G; Newman S; Fleming J; Siekmeier R; Ehrmann S; Scheuch G; Hochhaus G; Hickey A
    Ther Deliv; 2013 Mar; 4(3):343-67. PubMed ID: 23442081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing bioequivalence for inhaled drugs; weighing the evidence.
    Daley-Yates PT; Parkins DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1297-308. PubMed ID: 21699442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products.
    Fleming J; Bailey DL; Chan HK; Conway J; Kuehl PJ; Laube BL; Newman S
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S29-51. PubMed ID: 23215845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in establishing bioequivalence of inhaled compounds.
    Mayers I; Bhutani M
    Expert Opin Drug Deliv; 2018 Feb; 15(2):153-162. PubMed ID: 28918665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.
    Khoubnasabjafari M; Rahimpour E; Samini M; Jouyban-Gharamaleki V; Chen L; Chen D; Chan HK; Jouyban A
    Daru; 2019 Jun; 27(1):517-524. PubMed ID: 30847847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung imaging - two dimensional gamma scintigraphy, SPECT, CT and PET.
    Conway J
    Adv Drug Deliv Rev; 2012 Mar; 64(4):357-68. PubMed ID: 22310158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of comparative performance of orally inhaled drug products in view of the classical bioequivalence paradigms: an analysis of the current scientific and regulatory dilemmas of inhaler evaluation.
    Horhota ST
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):408-13. PubMed ID: 25237840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies.
    Lee Z; Berridge MS
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1324-31. PubMed ID: 12585715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical technique to recover the third dimension in planar imaging of inhaled aerosols: (1) impact on spatial quantification.
    Tossici-Bolt L; Fleming JS; Conway JH; Martonen TB
    J Aerosol Med; 2006; 19(4):565-79. PubMed ID: 17196084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence assessment of pharmaceutical aerosol products through IVIVC.
    Sandell D
    Adv Drug Deliv Rev; 2021 Sep; 176():113895. PubMed ID: 34329687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods of calculating lung delivery and deposition of aerosol particles.
    Kim CS
    Respir Care; 2000 Jun; 45(6):695-711. PubMed ID: 10894462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in Aerosol Medicine.
    Corcoran TE
    Respir Care; 2015 Jun; 60(6):850-5; discussion 855-7. PubMed ID: 26070579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report.
    Evans C; Cipolla D; Chesworth T; Agurell E; Ahrens R; Conner D; Dissanayake S; Dolovich M; Doub W; Fuglsang A; García Arieta A; Golden M; Hermann R; Hochhaus G; Holmes S; Lafferty P; Lyapustina S; Nair P; O'Connor D; Parkins D; Peterson I; Reisner C; Sandell D; Singh GJ; Weda M; Watson P
    J Aerosol Med Pulm Drug Deliv; 2012 Jun; 25(3):117-39. PubMed ID: 22413806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in assessing regional distribution of inhaled drug in the human lungs.
    Newman S; Fleming J
    Expert Opin Drug Deliv; 2011 Jul; 8(7):841-55. PubMed ID: 21554149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
    Adams WP; Ahrens RC; Chen ML; Christopher D; Chowdhury BA; Conner DP; Dalby R; Fitzgerald K; Hendeles L; Hickey AJ; Hochhaus G; Laube BL; Lucas P; Lee SL; Lyapustina S; Li B; O'Connor D; Parikh N; Parkins DA; Peri P; Pitcairn GR; Riebe M; Roy P; Shah T; Singh GJ; Sharp SS; Suman JD; Weda M; Woodcock J; Yu L
    J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):1-29. PubMed ID: 20131983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography (PET) for assessing aerosol deposition of orally inhaled drug products.
    Dolovich MB; Bailey DL
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S52-71. PubMed ID: 23215847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and impact on design of bioequivalence studies.
    Van Peer A
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standards for bioequivalence of inhaled products.
    Chrystyn H
    Clin Pharmacokinet; 1994 Jan; 26(1):1-6. PubMed ID: 8137595
    [No Abstract]   [Full Text] [Related]  

  • 19. The co-imaging of gamma camera measurements of aerosol deposition and respiratory anatomy.
    Conway J; Fleming J; Bennett M; Havelock T
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):123-30. PubMed ID: 23517170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence study designs for generic solid oral anticancer drug products: scientific and regulatory considerations.
    Kaur P; Chaurasia CS; Davit BM; Conner DP
    J Clin Pharmacol; 2013 Dec; 53(12):1252-60. PubMed ID: 23996908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.